INDOCO — INDOCO REMEDIES Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹18.38bn
- IN₹28.74bn
- IN₹18.45bn
Annual cashflow statement for INDOCO REMEDIES, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,366 | 1,928 | 1,243 | -754 | -1,036 |
| Depreciation | |||||
| Non-Cash Items | 81.7 | 503 | 572 | 708 | 1,199 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,499 | -1,348 | -1,173 | -143 | 495 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,738 | 1,788 | 1,560 | 949 | 1,922 |
| Capital Expenditures | -1,253 | -2,073 | -4,260 | -3,562 | -1,475 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 39.2 | -9.22 | -65.2 | 170 | 459 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,214 | -2,082 | -4,325 | -3,391 | -1,016 |
| Financing Cash Flow Items | -150 | -272 | -361 | -639 | -1,231 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -444 | 228 | 2,804 | 2,414 | -768 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 80.5 | -65.3 | 39.3 | -27.6 | 138 |